216 related articles for article (PubMed ID: 11134831)
1. Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
Rozenberg S
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):86-91. PubMed ID: 11134831
[TBL] [Abstract][Full Text] [Related]
2. Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
Rozenberg S; Caubel P; Lim PC
Int J Gynaecol Obstet; 2001 Mar; 72(3):235-43. PubMed ID: 11226444
[TBL] [Abstract][Full Text] [Related]
3. Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.
Curran MP; Wagstaff AJ
Drugs Aging; 2001; 18(11):863-85. PubMed ID: 11772126
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
[TBL] [Abstract][Full Text] [Related]
5. Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.
Curran MP; Wagstaff AJ
Treat Endocrinol; 2002; 1(2):127-9. PubMed ID: 15765628
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
7. Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
Ylikorkala O; Wahlström T; Caubel P; Lane R
Acta Obstet Gynecol Scand; 2002 Jul; 81(7):654-60. PubMed ID: 12190841
[TBL] [Abstract][Full Text] [Related]
8. Hormonal replacement regimens and bleeding.
Dören M
Maturitas; 2000 Jan; 34 Suppl 1():S17-23. PubMed ID: 10759060
[TBL] [Abstract][Full Text] [Related]
9. Disturbances of endometrial bleeding with hormone replacement therapy.
Thomas AM; Hickey M; Fraser IS
Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
[TBL] [Abstract][Full Text] [Related]
10. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
11. Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.
MacLennan AH; MacLennan A; Wenzel S; Chambers HM; Eckert K
Med J Aust; 1993 Jul; 159(2):102-6. PubMed ID: 8336583
[TBL] [Abstract][Full Text] [Related]
12. Endometrial safety of hormone replacement therapy: review of literature.
Van Gorp T; Neven P
Maturitas; 2002 Jun; 42(2):93-104. PubMed ID: 12065168
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
[TBL] [Abstract][Full Text] [Related]
15. Prevention of endometrial abnormalities.
Whitehead MI
Acta Obstet Gynecol Scand Suppl; 1986; 134():81-91. PubMed ID: 3028029
[TBL] [Abstract][Full Text] [Related]
16. The uterus and the menopause.
Rees MC
Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903
[TBL] [Abstract][Full Text] [Related]
17. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
[TBL] [Abstract][Full Text] [Related]
18. HRT dosing regimens: continuous versus cyclic-pros and cons.
Shoupe D
Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
[TBL] [Abstract][Full Text] [Related]
19. Continuous combined hormone replacement therapy and risk of endometrial cancer.
Hill DA; Weiss NS; Beresford SA; Voigt LF; Daling JR; Stanford JL; Self S
Am J Obstet Gynecol; 2000 Dec; 183(6):1456-61. PubMed ID: 11120510
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
